nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—Misoprostol—PTGER3—polycystic ovary syndrome	0.0169	0.563	CrCbGaD
Alprostadil—PTGER2—adrenal cortex—polycystic ovary syndrome	0.0143	0.054	CbGeAlD
Alprostadil—PTGER2—endometrium—polycystic ovary syndrome	0.0128	0.0482	CbGeAlD
Alprostadil—PTGER2—uterus—polycystic ovary syndrome	0.0118	0.0444	CbGeAlD
Alprostadil—PTGER2—adipose tissue—polycystic ovary syndrome	0.0115	0.0434	CbGeAlD
Alprostadil—Tooth abscess—Metformin—polycystic ovary syndrome	0.0105	0.0952	CcSEcCtD
Alprostadil—PTGER2—adrenal gland—polycystic ovary syndrome	0.0103	0.039	CbGeAlD
Alprostadil—PTGER2—female gonad—polycystic ovary syndrome	0.00961	0.0363	CbGeAlD
Alprostadil—PTGER2—vagina—polycystic ovary syndrome	0.00956	0.0361	CbGeAlD
Alprostadil—PTGER1—female gonad—polycystic ovary syndrome	0.00911	0.0344	CbGeAlD
Alprostadil—PTGER1—endocrine gland—polycystic ovary syndrome	0.00848	0.032	CbGeAlD
Alprostadil—Hypothermia—Metformin—polycystic ovary syndrome	0.00779	0.071	CcSEcCtD
Alprostadil—Body temperature decreased—Metformin—polycystic ovary syndrome	0.00779	0.071	CcSEcCtD
Alprostadil—SLCO2A1—adrenal cortex—polycystic ovary syndrome	0.00731	0.0276	CbGeAlD
Alprostadil—Respiratory distress—Metformin—polycystic ovary syndrome	0.00687	0.0626	CcSEcCtD
Alprostadil—PTGIR—adipose tissue—polycystic ovary syndrome	0.00673	0.0254	CbGeAlD
Alprostadil—SLCO2A1—endometrium—polycystic ovary syndrome	0.00653	0.0247	CbGeAlD
Alprostadil—Dinoprost Tromethamine—PTGER3—polycystic ovary syndrome	0.00618	0.205	CrCbGaD
Alprostadil—PTGIR—adrenal gland—polycystic ovary syndrome	0.00604	0.0228	CbGeAlD
Alprostadil—SLCO2A1—uterus—polycystic ovary syndrome	0.00602	0.0227	CbGeAlD
Alprostadil—SLCO3A1—pituitary gland—polycystic ovary syndrome	0.00597	0.0225	CbGeAlD
Alprostadil—SLCO3A1—adipose tissue—polycystic ovary syndrome	0.00594	0.0224	CbGeAlD
Alprostadil—SLCO2A1—pituitary gland—polycystic ovary syndrome	0.00591	0.0223	CbGeAlD
Alprostadil—SLCO2A1—adipose tissue—polycystic ovary syndrome	0.00588	0.0222	CbGeAlD
Alprostadil—Fungal infection—Metformin—polycystic ovary syndrome	0.00566	0.0515	CcSEcCtD
Alprostadil—PTGIR—female gonad—polycystic ovary syndrome	0.00563	0.0213	CbGeAlD
Alprostadil—ABCC5—pituitary gland—polycystic ovary syndrome	0.0054	0.0204	CbGeAlD
Alprostadil—ABCC5—adipose tissue—polycystic ovary syndrome	0.00538	0.0203	CbGeAlD
Alprostadil—SLCO3A1—adrenal gland—polycystic ovary syndrome	0.00533	0.0201	CbGeAlD
Alprostadil—SLCO2A1—adrenal gland—polycystic ovary syndrome	0.00528	0.0199	CbGeAlD
Alprostadil—PTGIR—endocrine gland—polycystic ovary syndrome	0.00524	0.0198	CbGeAlD
Alprostadil—SLCO3A1—female gonad—polycystic ovary syndrome	0.00497	0.0188	CbGeAlD
Alprostadil—SLCO3A1—vagina—polycystic ovary syndrome	0.00494	0.0187	CbGeAlD
Alprostadil—Accidental injury—Metformin—polycystic ovary syndrome	0.00494	0.045	CcSEcCtD
Alprostadil—SLCO2A1—female gonad—polycystic ovary syndrome	0.00492	0.0186	CbGeAlD
Alprostadil—SLCO2A1—vagina—polycystic ovary syndrome	0.00489	0.0185	CbGeAlD
Alprostadil—ABCC5—adrenal gland—polycystic ovary syndrome	0.00483	0.0182	CbGeAlD
Alprostadil—Dinoprostone—PTGER3—polycystic ovary syndrome	0.00475	0.158	CrCbGaD
Alprostadil—SLCO3A1—endocrine gland—polycystic ovary syndrome	0.00462	0.0175	CbGeAlD
Alprostadil—SLCO2A1—endocrine gland—polycystic ovary syndrome	0.00458	0.0173	CbGeAlD
Alprostadil—ABCC5—female gonad—polycystic ovary syndrome	0.0045	0.017	CbGeAlD
Alprostadil—ABCC5—vagina—polycystic ovary syndrome	0.00447	0.0169	CbGeAlD
Alprostadil—SLCO2B1—uterus—polycystic ovary syndrome	0.00431	0.0163	CbGeAlD
Alprostadil—SLCO2B1—adipose tissue—polycystic ovary syndrome	0.00421	0.0159	CbGeAlD
Alprostadil—ABCC4—uterus—polycystic ovary syndrome	0.00381	0.0144	CbGeAlD
Alprostadil—SLCO2B1—adrenal gland—polycystic ovary syndrome	0.00378	0.0143	CbGeAlD
Alprostadil—ABCC4—adipose tissue—polycystic ovary syndrome	0.00373	0.0141	CbGeAlD
Alprostadil—SLCO2B1—female gonad—polycystic ovary syndrome	0.00352	0.0133	CbGeAlD
Alprostadil—Nasal congestion—Metformin—polycystic ovary syndrome	0.00348	0.0317	CcSEcCtD
Alprostadil—Injury—Metformin—polycystic ovary syndrome	0.00345	0.0314	CcSEcCtD
Alprostadil—ABCC4—adrenal gland—polycystic ovary syndrome	0.00335	0.0126	CbGeAlD
Alprostadil—SLCO2B1—endocrine gland—polycystic ovary syndrome	0.00328	0.0124	CbGeAlD
Alprostadil—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00325	0.0296	CcSEcCtD
Alprostadil—Lethargy—Metformin—polycystic ovary syndrome	0.00323	0.0295	CcSEcCtD
Alprostadil—Pain in extremity—Metformin—polycystic ovary syndrome	0.00317	0.0289	CcSEcCtD
Alprostadil—ABCC4—female gonad—polycystic ovary syndrome	0.00312	0.0118	CbGeAlD
Alprostadil—ABCC4—endocrine gland—polycystic ovary syndrome	0.0029	0.011	CbGeAlD
Alprostadil—Influenza—Metformin—polycystic ovary syndrome	0.00274	0.025	CcSEcCtD
Alprostadil—Sweating increased—Metformin—polycystic ovary syndrome	0.00267	0.0243	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00255	0.0232	CcSEcCtD
Alprostadil—Bradycardia—Metformin—polycystic ovary syndrome	0.00223	0.0203	CcSEcCtD
Alprostadil—Rhinitis—Metformin—polycystic ovary syndrome	0.0022	0.02	CcSEcCtD
Alprostadil—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00218	0.0199	CcSEcCtD
Alprostadil—Flushing—Metformin—polycystic ovary syndrome	0.00204	0.0185	CcSEcCtD
Alprostadil—Erythema—Metformin—polycystic ovary syndrome	0.00191	0.0174	CcSEcCtD
Alprostadil—Muscle spasms—Metformin—polycystic ovary syndrome	0.00184	0.0167	CcSEcCtD
Alprostadil—Syncope—Metformin—polycystic ovary syndrome	0.00171	0.0156	CcSEcCtD
Alprostadil—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00168	0.0153	CcSEcCtD
Alprostadil—Hypertension—Metformin—polycystic ovary syndrome	0.00165	0.015	CcSEcCtD
Alprostadil—Discomfort—Metformin—polycystic ovary syndrome	0.00161	0.0146	CcSEcCtD
Alprostadil—Oedema—Metformin—polycystic ovary syndrome	0.00156	0.0142	CcSEcCtD
Alprostadil—Infection—Metformin—polycystic ovary syndrome	0.00155	0.0141	CcSEcCtD
Alprostadil—Shock—Metformin—polycystic ovary syndrome	0.00153	0.014	CcSEcCtD
Alprostadil—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00153	0.0139	CcSEcCtD
Alprostadil—Skin disorder—Metformin—polycystic ovary syndrome	0.00151	0.0138	CcSEcCtD
Alprostadil—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00151	0.0137	CcSEcCtD
Alprostadil—Dinoprostone—CYP11A1—polycystic ovary syndrome	0.00147	0.0489	CrCbGaD
Alprostadil—Hypotension—Metformin—polycystic ovary syndrome	0.00146	0.0133	CcSEcCtD
Alprostadil—Dyspepsia—Metformin—polycystic ovary syndrome	0.00137	0.0125	CcSEcCtD
Alprostadil—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00128	0.0117	CcSEcCtD
Alprostadil—Abdominal pain—Metformin—polycystic ovary syndrome	0.00123	0.0112	CcSEcCtD
Alprostadil—Asthenia—Metformin—polycystic ovary syndrome	0.00112	0.0102	CcSEcCtD
Alprostadil—Pruritus—Metformin—polycystic ovary syndrome	0.0011	0.01	CcSEcCtD
Alprostadil—Diarrhoea—Metformin—polycystic ovary syndrome	0.00107	0.00971	CcSEcCtD
Alprostadil—Dizziness—Metformin—polycystic ovary syndrome	0.00103	0.00938	CcSEcCtD
Alprostadil—Rash—Metformin—polycystic ovary syndrome	0.000982	0.00895	CcSEcCtD
Alprostadil—Dermatitis—Metformin—polycystic ovary syndrome	0.000981	0.00894	CcSEcCtD
Alprostadil—Headache—Metformin—polycystic ovary syndrome	0.000976	0.00889	CcSEcCtD
Alprostadil—Nausea—Metformin—polycystic ovary syndrome	0.000925	0.00843	CcSEcCtD
Alprostadil—Dinoprostone—CYP19A1—polycystic ovary syndrome	0.00076	0.0253	CrCbGaD
Alprostadil—PTGER1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000255	0.000429	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000255	0.000429	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000254	0.000427	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000254	0.000427	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000254	0.000427	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000253	0.000424	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000253	0.000424	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000253	0.000424	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—VEGFA—polycystic ovary syndrome	0.000252	0.000423	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000249	0.000418	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000244	0.00041	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000242	0.000407	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000242	0.000407	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00024	0.000403	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00024	0.000403	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00024	0.000403	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00024	0.000403	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	0.00024	0.000403	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000238	0.0004	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000238	0.000399	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000232	0.000389	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FST—polycystic ovary syndrome	0.000232	0.000389	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000231	0.000388	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000231	0.000388	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00023	0.000387	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000229	0.000384	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—GNAS—polycystic ovary syndrome	0.000228	0.000383	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RPL37A—polycystic ovary syndrome	0.000227	0.000382	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000226	0.00038	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000226	0.000379	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000226	0.000379	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000224	0.000377	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000224	0.000377	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000224	0.000376	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000221	0.000372	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000221	0.000371	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000218	0.000366	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000218	0.000366	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HMMR—polycystic ovary syndrome	0.000215	0.000362	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000214	0.000359	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000213	0.000359	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000212	0.000356	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000212	0.000356	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000212	0.000356	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000212	0.000356	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000212	0.000356	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000209	0.000351	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000206	0.000347	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000206	0.000347	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—STAR—polycystic ovary syndrome	0.000202	0.00034	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000202	0.00034	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000202	0.000339	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000199	0.000333	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000197	0.000331	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000194	0.000326	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000193	0.000324	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000193	0.000324	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000188	0.000316	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000188	0.000316	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000184	0.000309	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000181	0.000304	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—HMMR—polycystic ovary syndrome	0.00018	0.000303	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000178	0.000298	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKR1C1—polycystic ovary syndrome	0.000177	0.000298	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PLAT—polycystic ovary syndrome	0.000177	0.000298	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000175	0.000295	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000175	0.000295	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000173	0.000291	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—HSD3B1—polycystic ovary syndrome	0.000172	0.000289	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000172	0.000289	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000172	0.000289	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000171	0.000287	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000171	0.000287	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000171	0.000287	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000171	0.000287	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00017	0.000285	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000165	0.000277	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000165	0.000277	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000165	0.000277	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000165	0.000277	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF18—polycystic ovary syndrome	0.000165	0.000277	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RBP4—polycystic ovary syndrome	0.000163	0.000274	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000162	0.000273	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000162	0.000272	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PGR—polycystic ovary syndrome	0.00016	0.00027	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00016	0.00027	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00016	0.00027	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—LHB—polycystic ovary syndrome	0.000157	0.000264	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FST—polycystic ovary syndrome	0.000156	0.000263	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FST—polycystic ovary syndrome	0.000156	0.000263	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000156	0.000261	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000156	0.000261	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000154	0.000259	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000154	0.000259	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—HSD3B2—polycystic ovary syndrome	0.000153	0.000258	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000153	0.000258	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LHB—polycystic ovary syndrome	0.000153	0.000256	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000153	0.000256	CbGpPWpGaD
Alprostadil—ABCC5—Disease—GAB1—polycystic ovary syndrome	0.00015	0.000253	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000149	0.000251	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000149	0.000251	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000149	0.000251	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000149	0.000251	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AKR1C1—polycystic ovary syndrome	0.000149	0.00025	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IGF1—polycystic ovary syndrome	0.000148	0.000248	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—AKT2—polycystic ovary syndrome	0.000148	0.000248	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NAMPT—polycystic ovary syndrome	0.000146	0.000246	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000144	0.000243	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000144	0.000243	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000144	0.000242	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000144	0.000242	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000144	0.000241	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000143	0.00024	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SCT—polycystic ovary syndrome	0.000143	0.00024	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000142	0.000239	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000141	0.000237	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000141	0.000237	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—SERPINE1—polycystic ovary syndrome	0.00014	0.000236	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00014	0.000236	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000139	0.000233	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000138	0.000232	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—SULT2A1—polycystic ovary syndrome	0.000137	0.00023	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKR1C3—polycystic ovary syndrome	0.000137	0.000229	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000136	0.000229	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000136	0.000229	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—GNAS—polycystic ovary syndrome	0.000136	0.000228	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TNRC6B—polycystic ovary syndrome	0.000134	0.000226	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000134	0.000225	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000134	0.000225	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000133	0.000223	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000133	0.000223	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—RRM2—polycystic ovary syndrome	0.000132	0.000222	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000132	0.000222	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000131	0.000221	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000131	0.00022	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000131	0.00022	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000131	0.000219	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PRL—polycystic ovary syndrome	0.00013	0.000219	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—YAP1—polycystic ovary syndrome	0.000128	0.000214	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000125	0.000211	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000124	0.000208	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000124	0.000208	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000123	0.000207	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NAMPT—polycystic ovary syndrome	0.000123	0.000206	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000122	0.000206	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000122	0.000206	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP11A1—polycystic ovary syndrome	0.000121	0.000203	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000118	0.000198	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—INSR—polycystic ovary syndrome	0.000117	0.000197	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000117	0.000197	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TCF7L2—polycystic ovary syndrome	0.000115	0.000193	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000115	0.000192	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AKR1C3—polycystic ovary syndrome	0.000114	0.000192	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SLC2A4—polycystic ovary syndrome	0.000113	0.00019	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP17A1—polycystic ovary syndrome	0.000113	0.000189	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000112	0.000187	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000111	0.000187	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000111	0.000187	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00011	0.000184	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00011	0.000184	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000109	0.000183	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PGR—polycystic ovary syndrome	0.000108	0.000182	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000108	0.000182	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PRL—polycystic ovary syndrome	0.000108	0.000181	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000107	0.00018	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000101	0.000169	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000101	0.000169	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000101	0.000169	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000101	0.000169	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TH—polycystic ovary syndrome	9.74e-05	0.000164	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—POMC—polycystic ovary syndrome	9.71e-05	0.000163	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—POMC—polycystic ovary syndrome	9.71e-05	0.000163	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—VEGFA—polycystic ovary syndrome	9.65e-05	0.000162	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ATF1—polycystic ovary syndrome	9.61e-05	0.000161	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ATF1—polycystic ovary syndrome	9.61e-05	0.000161	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—SLC2A4—polycystic ovary syndrome	9.48e-05	0.000159	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.38e-05	0.000157	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.38e-05	0.000157	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.33e-05	0.000157	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.33e-05	0.000157	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IRS2—polycystic ovary syndrome	9.17e-05	0.000154	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NCOR1—polycystic ovary syndrome	9.05e-05	0.000152	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—LEP—polycystic ovary syndrome	8.98e-05	0.000151	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP19A1—polycystic ovary syndrome	8.91e-05	0.00015	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NRG1—polycystic ovary syndrome	8.88e-05	0.000149	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NGFR—polycystic ovary syndrome	8.87e-05	0.000149	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NGFR—polycystic ovary syndrome	8.87e-05	0.000149	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—POMC—polycystic ovary syndrome	8.82e-05	0.000148	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—POMC—polycystic ovary syndrome	8.82e-05	0.000148	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IGF1—polycystic ovary syndrome	8.81e-05	0.000148	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—AKT2—polycystic ovary syndrome	8.8e-05	0.000148	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRL—polycystic ovary syndrome	8.79e-05	0.000148	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRL—polycystic ovary syndrome	8.79e-05	0.000148	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.47e-05	0.000142	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.47e-05	0.000142	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SERPINE1—polycystic ovary syndrome	8.36e-05	0.00014	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.34e-05	0.00014	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.34e-05	0.00014	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IRS1—polycystic ovary syndrome	8.01e-05	0.000134	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTHFR—polycystic ovary syndrome	8e-05	0.000134	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GNAS—polycystic ovary syndrome	7.95e-05	0.000134	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GNAS—polycystic ovary syndrome	7.74e-05	0.00013	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GNAS—polycystic ovary syndrome	7.74e-05	0.00013	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—POMC—polycystic ovary syndrome	7.71e-05	0.000129	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—INS—polycystic ovary syndrome	7.67e-05	0.000129	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IRS2—polycystic ovary syndrome	7.61e-05	0.000128	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NCOR1—polycystic ovary syndrome	7.58e-05	0.000127	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IGF1—polycystic ovary syndrome	7.42e-05	0.000125	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKT2—polycystic ovary syndrome	7.41e-05	0.000124	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.37e-05	0.000124	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.37e-05	0.000124	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NRG1—polycystic ovary syndrome	7.23e-05	0.000121	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NRG1—polycystic ovary syndrome	7.23e-05	0.000121	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP1A1—polycystic ovary syndrome	7.18e-05	0.000121	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.04e-05	0.000118	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MTHFR—polycystic ovary syndrome	6.7e-05	0.000112	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IRS1—polycystic ovary syndrome	6.64e-05	0.000112	CbGpPWpGaD
Alprostadil—ABCC5—Disease—INS—polycystic ovary syndrome	6.36e-05	0.000107	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IRS2—polycystic ovary syndrome	6.2e-05	0.000104	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.2e-05	0.000104	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKT2—polycystic ovary syndrome	6.15e-05	0.000103	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LEP—polycystic ovary syndrome	6.06e-05	0.000102	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LEP—polycystic ovary syndrome	6.06e-05	0.000102	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SERPINE1—polycystic ovary syndrome	5.84e-05	9.81e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—polycystic ovary syndrome	5.75e-05	9.66e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—polycystic ovary syndrome	5.67e-05	9.53e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARG—polycystic ovary syndrome	5.43e-05	9.12e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.41e-05	9.08e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IRS1—polycystic ovary syndrome	5.41e-05	9.08e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—POMC—polycystic ovary syndrome	5.36e-05	9e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—INS—polycystic ovary syndrome	5.33e-05	8.95e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—POMC—polycystic ovary syndrome	5.21e-05	8.75e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—POMC—polycystic ovary syndrome	5.21e-05	8.75e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—INS—polycystic ovary syndrome	5.18e-05	8.7e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—INS—polycystic ovary syndrome	5.18e-05	8.7e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.01e-05	8.41e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IGF1—polycystic ovary syndrome	5.01e-05	8.41e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.01e-05	8.41e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKT2—polycystic ovary syndrome	5.01e-05	8.41e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.84e-05	8.14e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.76e-05	7.99e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.76e-05	7.99e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.83e-05	6.43e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—polycystic ovary syndrome	3.83e-05	6.43e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—polycystic ovary syndrome	3.35e-05	5.63e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.27e-05	5.5e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.27e-05	5.5e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—polycystic ovary syndrome	2.78e-05	4.67e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—polycystic ovary syndrome	2.26e-05	3.8e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—polycystic ovary syndrome	2.26e-05	3.8e-05	CbGpPWpGaD
